LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10061-1 NU7441
KU 57788
 LSM-1061 11327430
10158-1 AZD 5438
KIN001-239
 LSM-1159 16747683
10017-1 HG-6-64-01
KIN001-206
 LSM-43248
10072-1 PF562271
KIN001-205
 LSM-1072 11713159
10100-1 JNK-9L
KIN001-204
 LSM-36386 25222038
10059-1 AZD-6482
KIN001-193
 LSM-1059 44137675
10109-1 YM 201636
Kin001-170
 LSM-1109 9956222
10035-1 Sigma A6730
KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor
 LSM-1035 10196499
10018-1 Neratinib
HKI-272
 LSM-42778 53398697
10014-1 GW843682X
GW843682
 LSM-1014 9826308
10051-1 Lapatinib
GW-572016; Tykerb
 LSM-1051 208908
10146-1 Omipalisib
GSK2126458; GSK2126458A
 LSM-1147 25167777
10142-1 Trametinib
GSK-1120212; GSK1120212; GSK1120212B; JTP-74057
 LSM-1143 11707110
10023-1 Imatinib
Gleevec; Glivec; CGP-57148B; STI-571
 LSM-1023 5291
10011-1 Alvocidib
Flavopiridol; HMR-1275; L868275
 LSM-1011 5287969
10159-1 Pelitinib
EKB-569
 LSM-1160 216467
10115-1 LDN-193189
DM 3189
 LSM-1115 25195294
10140-1 Momelotinib
CYT387
 LSM-1141 25062766
10180-1 CHIR-99021
CT99021; KIN001-157
 LSM-1181 9956119
10479-1 Mitoxantrone
CL 232325; CL-232325; DHAQ; Novantron; Novantrone
 LSM-2481 4212
10048-1 PD184352
CI-1040
 LSM-1048 6918454
10120-1 Canertinib
CI-1033; PD-183805
 LSM-1120 156414
10233-1 Alpelisib
BYL719
 LSM-4256 56649450
10177-1 Brivanib
BMS-540215
 LSM-1178 11451527
10132-1 SNS-032
BMS-387032
 LSM-1132 3025986